Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 60 (3) , 303-307
- https://doi.org/10.1007/bf00426672
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of actionPsychopharmacology, 1978
- Different behavioural patterns induced by apomorphine: Evidence that the method of administration determines the behavioural response to the drugEuropean Journal of Pharmacology, 1977
- Differential attenuation of some effects of haloperidol in rats given scopolamineEuropean Journal of Pharmacology, 1976
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical AppraisalPharmacopsychiatry, 1975
- Antischizophrenic drugs: Affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effectsJournal of Psychiatric Research, 1974
- Anti-muscarinic properties of neuroleptics and drug-induced ParkinsonismNature, 1974
- The role of telencephalic dopaminergic systems in the mediation of apomorphine-sterrotyped behaviourEuropean Journal of Pharmacology, 1973
- Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?1973
- The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine).1971